Braveheart Bio
BRVE
20.39
+1.12
+5.81%
Braveheart Bio
US · BRVE
#2845 by market cap
Listed 2026
20.39
+1.12
+5.81%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48Market Newswire · 2026/9/1
-
Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 2026/10/1
-
Rating change
Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)TipRanks · 2026/9/7
-
Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/11/10
-
Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Raises Target Price to $49Market Newswire · 2026/11/12
-
Braveheart Bio, Inc. (BRVE) Receives a Buy From Cantor FitzgeraldTipRanks · 2026/10/20
-
Rating change
Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 2026/9/9
-
Cantor Fitzgerald Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/10/20
-
Rating change
Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/9/9
-
Rating change
Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)TipRanks · 2026/9/9
-
Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/10/1
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Braveheart Bio discussion 0 comments